Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Hyperinflation
- Lung volume reduction for COPD
- Lung volume reduction surgery (LVRS)
- LVRS vs. medical therapy
- Changes in lung volumes post LVRS
- Surgical mortality in practice is higher
- The national emphysema treatment trial (NETT)
- NETT - inclusion and exclusion
- NETT - results
- Kaplan-Meier estimates of death probability
- NETT - initial results
- LVRS after the NETT
- Longer term outcomes of NETT
- Patient selection for LVRS
- Surgery for bullae
- Operating volumes during exercise in bullectomy
- Elective surgery for giant bullous emphysema
- ATS / ERS COPD guidelines
- Other methods of lung volume reduction
- Bronchoscopic lung volume reduction
- Valves
- Successful lung volume reduction using valve (1)
- Successful lung volume reduction using valve (2)
- Change in endurance time after BLVR
- Successful BLVR is associated with survival
- The VENT trial (1)
- The VENT trial (2)
- Baseline characteristics - The VENT trial
- Primary outcomes at 6 months - The VENT trial
- Adverse events at 90 days - VENT study
- Heterogeneity effects on response to treatment
- VENT trial - summary
- Spiration valves
- Airway bypass (1)
- Airway bypass- demonstration
- CASSA report
- Airway bypass (2)
- EASE trial
- EASE trail - methods and participants
- EASE trail - peri-procedure safety
- 6 month primary safety endpoint
- Bronchoscopy review of exhale stents
- Short-lived benefits for airway bypass
- Airway bypass - improvement needed
- Future approaches
- Transpleural airway bypass 'spiracles'
- Extrapulmonary airway bypass
- Device - continual development
- Lung volume reduction coil PneumRx inc (1)
- Lung volume reduction coil PneumRx inc (2)
- Biological lung volume reduction
- Blood lung volume reduction
- Bronchoscopic Thermal Vapor Ablation
- Conclusion
Topics Covered
- Hyperinflation in COPD
- Lung volume reduction surgery (LVRS)
- Bullectomy
- Bronchoscopic techniques including valves, airway bypass, coils, steam and fibrin glue
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Hopkinson, N. (2012, July 31). Lung volume reduction: advances in COPD [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 6, 2024, from https://doi.org/10.69645/KOZH1722.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Nick Hopkinson has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.